Val-You Based Care
In this episode of Val-You Based Care, Dr. Kimberly Ku sits down with Elizabeth Klumpp, Group Editorial Director at Haymarket Oncology, for a wide-ranging conversation on some of the most important clinical trial presentations emerging from ASCO—and what they reveal about the future of cancer care. Together, they explore several groundbreaking studies reshaping oncology across pancreatic cancer, prostate cancer, lung cancer, and sarcoma. The discussion highlights how cancer treatment is increasingly moving away from one-size-fits-all approaches and toward biomarker-driven, biology-focused care. The episode examines the excitement surrounding the Rasolute 302 study in pancreatic cancer and its potential to introduce new oral treatment options beyond traditional chemotherapy. It also explores the Proteus study and the growing role of treatment intensification and multidisciplinary collaboration in localized prostate cancer care. Dr. Ku and Klumpp further discuss the Libretto 432 study and the evolution of precision oncology into earlier-stage disease settings, emphasizing the urgent need for comprehensive molecular testing at diagnosis. They also unpack the Sarco41 study as an example of how oncology is beginning to transcend organ-based classifications in favor of targeting shared tumor biology. Finally, the conversation turns toward the future—examining how artificial intelligence may fundamentally change clinical trial design and cancer treatment itself. From “AI twins” to adaptive treatment modeling, this episode offers a thoughtful look at where oncology may be headed next. At its core, this discussion is about possibility: how innovation, collaboration, and evolving scientific thinking may redefine what cancer care looks like in the years ahead. Chapters: 0:00 - Introduction 0:42 - The Rasolute 302 study 3:20 - Clinical signals in prostate cancer analysis 5:37 - The value of genetic testing 6:55 - The Sarco41 study 12:38 - Closing remarks
9 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Val-You Based Care!